<DOC>
	<DOCNO>NCT00694213</DOCNO>
	<brief_summary>The trial enroll 47 subject . Qualified normal healthy volunteer enrol study receive vaccine placebo vaccine . Subjects receive 2 vaccination BiojectorÂ® 2000 , follow 6 month evaluate safety immune system 's response vaccine . The safety immune system 's response study throughout trial .</brief_summary>
	<brief_title>Pandemic Influenza Plasmid DNA Vaccines ( Needle-Free )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>18 45 year age Able provide inform consent follow 6 month No immunomodulatory therapy within past 6 month No evidence immunodeficiency pregnancy No laboratory evidence clinically significant medical disease No history previous pDNA immunization No influenza immunization within past 30 day No blood donation within 30 day screen visit No history bleed disorder No use aspirin and/or anticoagulant within 2 week administration investigational vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Pandemic Influenza</keyword>
	<keyword>Avian Influenza</keyword>
	<keyword>DNA Vaccines</keyword>
	<keyword>Antibody</keyword>
	<keyword>T Cells</keyword>
	<keyword>HA/NP/M2</keyword>
	<keyword>Biojector</keyword>
</DOC>